Literature DB >> 6195189

Stimulation of histamine release from human basophils by human platelet factor 4.

L L Brindley, J M Sweet, E J Goetzl.   

Abstract

Human basophils were stimulated to release histamine noncytotoxically by purified human platelet factor 4 (PF4) and the synthetic substituent peptide PF4(59-70). Histamine release was augmented significantly by 10(-7) M PF4 and 10(-5) M PF4(59-70), increased in a concentration-dependent manner, and attained a maximum at 3 X 10(-5) M PF4 and 3 X 10(-4) M PF4(59-70) similar to that achieved by goat anti-human myeloma IgE. PF4 (1-60) failed to initiate the release of histamine, which confirmed that the critical determinant of activity is in the carboxy-terminal sequence. Histamine release from basophils by optimally effective concentrations of PF4 and PF4(59-70) reached a plateau by 1-3 min, as contrasted with 10 min or longer for anti-IgE. The elimination of calcium and magnesium from the buffer suppressed the release of histamine by anti-IgE by 79-83%, but had no effect on that elicited by PF4(59-70). The rate of uptake of [125I]PF4 by purified basophils was similar on a molar basis to the rate of release of histamine by the same concentrations of PF4. The noncytotoxic release of histamine from human basophils by PF4 thus is temporally and biochemically distinct from that mediated by IgE and may be similar to that evoked by other polycationic stimuli.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6195189      PMCID: PMC370405          DOI: 10.1172/JCI111077

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  14 in total

1.  Platelet factor 4: an inhibitor of collagenase.

Authors:  J Hiti-Harper; H Wohl; E Harper
Journal:  Science       Date:  1978-03-03       Impact factor: 47.728

Review 2.  Plasma levels of beta-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo.

Authors:  K L Kaplan; J Owen
Journal:  Blood       Date:  1981-02       Impact factor: 22.113

3.  Low affinity platelet factor 4 and high affinity platelet factor 4--two antiheparin factors secreted by human platelets.

Authors:  S Niewiarowski; B Rucinski; A Z Budzynski
Journal:  Thromb Haemost       Date:  1980-02-29       Impact factor: 5.249

4.  Vascular permeation of platelet factor 4 after endothelial injury.

Authors:  I D Goldberg; M B Stemerman; R I Handin
Journal:  Science       Date:  1980-08-01       Impact factor: 47.728

5.  Human platelet factor 4: subcellular localization and characteristics of release from intact platelets.

Authors:  R Ryo; R T Proffitt; T F Deuel
Journal:  Thromb Res       Date:  1980-03-01       Impact factor: 3.944

6.  Platelet activating factor (PAF) induced release of platelet factor 4 (PF4) in vitro and during IgE anaphylaxis in the rabbit.

Authors:  L M McManus; C A Morley; S P Levine; R N Pinckard
Journal:  J Immunol       Date:  1979-12       Impact factor: 5.422

7.  Purification and binding properties of human platelet factor four.

Authors:  R I Handin; H J Cohen
Journal:  J Biol Chem       Date:  1976-07-25       Impact factor: 5.157

8.  The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent.

Authors:  A E Bolton; W M Hunter
Journal:  Biochem J       Date:  1973-07       Impact factor: 3.857

9.  A neutrophil-immobilizing factor derived from human leukocytes. I. Generation and partial characterization.

Authors:  E J Goetzl; K F Austen
Journal:  J Exp Med       Date:  1972-12-01       Impact factor: 14.307

10.  Mediators of inflammation in leukocyte lysosomes. VI. Partial purification and characterization of a mast cell-rupturing component.

Authors:  W Seegers; A Janoff
Journal:  J Exp Med       Date:  1966-11-01       Impact factor: 14.307

View more
  19 in total

1.  Alterations in human leukocyte function induced by ingestion of eicosapentaenoic acid.

Authors:  D G Payan; M Y Wong; T Chernov-Rogan; F H Valone; W C Pickett; V A Blake; W M Gold; E J Goetzl
Journal:  J Clin Immunol       Date:  1986-09       Impact factor: 8.317

Review 2.  Platelets in Pulmonary Immune Responses and Inflammatory Lung Diseases.

Authors:  Elizabeth A Middleton; Andrew S Weyrich; Guy A Zimmerman
Journal:  Physiol Rev       Date:  2016-08-03       Impact factor: 37.312

Review 3.  Platelets in allergy. Assays and interpretation.

Authors:  M Joseph
Journal:  Clin Rev Allergy       Date:  1988

Review 4.  Bidirectional modulation of platelet and polymorphonuclear leukocyte activities.

Authors:  A Del Maschio; E Dejana; G Bazzoni
Journal:  Ann Hematol       Date:  1993-07       Impact factor: 3.673

5.  Platelet-leukocyte interaction: activation of rabbit platelets by FMLP-stimulated neutrophils.

Authors:  E Coëffier; D Joseph; M C Prévost; B B Vargaftig
Journal:  Br J Pharmacol       Date:  1987-10       Impact factor: 8.739

6.  Histamine release by platelet aggregation.

Authors:  P F Mannaioni; B Palmerani; A Pistelli; F Gambassi; E Giannella; T Bani Sacchi; E Masini
Journal:  Agents Actions       Date:  1990-04

7.  Effects of basophil-priming and stimulating cytokines on histamine release from isolated human skin mast cells.

Authors:  M Nitschke; K Sohn; D Dieckmann; B F Gibbs; H H Wolff; U Amon
Journal:  Arch Dermatol Res       Date:  1996-07       Impact factor: 3.017

8.  Comparative studies of the interaction of human and bovine platelet factor 4 with heparin using histidine NMR resonances as spectroscopic probes.

Authors:  C J Talpas; L Lee
Journal:  J Protein Chem       Date:  1993-06

9.  Heparin binding to platelet factor-4. An NMR and site-directed mutagenesis study: arginine residues are crucial for binding.

Authors:  K H Mayo; E Ilyina; V Roongta; M Dundas; J Joseph; C K Lai; T Maione; T J Daly
Journal:  Biochem J       Date:  1995-12-01       Impact factor: 3.857

10.  Inhibition of human neutrophil receptor-mediated uptake of N-formyl-met-leu-phe by platelet factor 4 (59-70).

Authors:  D W Goldman; A L Hannah; E J Goetzl
Journal:  Immunology       Date:  1985-01       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.